This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

The Hematopathology and Diagnostic Challenges of Rare Lymphomas

Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia
Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas
Chronic Lymphocytic Leukemia with Alterations in TP53
Mantel Cell Lymphoma
Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma
Plasmablastic Lymphoma and Primary Effusion Lymphoma
Novel Agents in Primary Central Nervous System Lymphoma
Adult T-Cell Leukemia/Lymphoma
Extranodal NK/T-Cell Lymphoma
Anaplastic Large Cell Lymphoma
Enteropathy-Associated T-Cell Lymphomas
Hepatosplenic T-Cell Lymphoma
Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.